扩张型心肌病基因型、表型与预后的交互作用
本研究前瞻性纳入837例扩张型心肌病患者,均行全基因组测序及心脏磁共振检查,按基因状态分为TTN变异、非TTN变异及基因阴性组。非TTN变异组纤维化负荷最重,LGE阳性率、范围及ECV均较高。非TTN变异独立预测心血管死亡/心脏移植及心脏性猝死,LGE与ECV部分介导其与不良预后的关联。
要点
- 非TTN变异DCM患者LGE阳性率高且常呈环形或心外膜下模式,阅片时应重点评估纤维化分布类型。
- LGE与ECV是非TTN变异影响DCM预后的部分中介因素,报告时应同时给出LGE范围与ECV数值。
- 无论LVEF≤35%还是>35%,非TTN变异患者预后均更差,提示基因信息对风险分层有增量价值。
核心结论
- 非TTN变异与更高的心肌纤维化负荷相关,并独立于常规CMR纤维化及功能表型提供预后信息。
- 心肌纤维化(LGE与ECV)部分介导非TTN变异与不良结局之间的关联。
研究设计与样本
- 前瞻性队列研究,纳入837例诊断明确的扩张型心肌病患者。
- 所有患者行全基因组测序及心脏磁共振检查,基因状态分为TTN变异、非TTN变异及基因阴性。
- CMR评估包括心脏结构功能、晚期钆增强(LGE)及T1 mapping。
关键影像表现/征象
- 非TTN变异组LGE阳性率为69.2%,高于TTN变异组的24.7%及基因阴性组的46.6%(P<0.001)。
- 非TTN变异组LGE范围更大,环形及心外膜下模式的频率更高。
- 非TTN变异组native T1及细胞外容积分数(ECV)值高于其他两组。
诊断标准与关键数值
- 非TTN变异独立预测心血管死亡/心脏移植(校正HR:2.39;95%CI:1.46-3.92;P<0.001)。
- 非TTN变异独立预测心脏性猝死(校正HR:3.26;95%CI:1.59-6.65;P=0.001)。
- LVEDVi、LGE及ECV与非TTN变异共同进入多变量Cox回归模型。
- LGE对非TTN变异与不良结局的关联具有部分中介效应(间接HR:1.26;95%CI:1.11-1.47;P=0.008)。
- ECV对非TTN变异与不良结局的关联具有部分中介效应(间接HR:1.29;95%CI:1.12-1.53;P=0.006)。
临床应用与阅片要点
- DCM患者报告LGE时,除存在与否和范围外,应描述LGE分布模式,环形或心外膜下模式需提示非TTN变异的可能。
- 在LVEF≤35%和>35%两个分层中非TTN变异患者预后均更差,基因信息可辅助CMR进行危险分层。
- LVEDVi和LVEF未显示显著中介效应,提示纤维化指标比心室重构指标更能反映非TTN变异的预后通路。
局限性
- 本研究为单中心前瞻性队列设计,结果外推性可能受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Dilated cardiomyopathy (DCM) is a heterogeneous myocardial disease with variable clinical outcomes. Although both genetic variants and cardiac magnetic resonance (CMR)-derived fibrosis markers are associated with prognosis, their interactions and relative contributions to disease progression remain incompletely understood.
OBJECTIVES: This study aims to explore the associations among genetic variants, CMR characteristics, and long-term prognosis in DCM.
METHODS: The authors prospectively enrolled patients diagnosed with DCM who underwent whole-genome sequencing and CMR examination. DCM-associated genetic status was classified as TTN variant, non-TTN variant, and genotype-negative. CMR evaluation included cardiac structure and function, late gadolinium enhancement (LGE), and T1 mapping. Clinical outcomes included cardiovascular death/heart transplantation, sudden cardiac death, and arrhythmic events.
RESULTS: Of the 837 enrolled patients, 163 (19.5%) carried pathogenic/likely pathogenic variants, including 78 (9.3%) non-TTN and 85 (10.2%) TTN variants. Patients with non-TTN variants demonstrated the greatest fibrosis burden, with higher LGE prevalence (69.2% vs 24.7% in patients with TTN variants and 46.6% in genotype-negative patients, P < 0.001), greater LGE extent, more frequent ring-like and subepicardial patterns, and higher native T1 and extracellular volume fraction (ECV) values. In multivariable Cox regression analysis, non-TTN variants independently predicted cardiovascular death/heart transplantation (adjusted HR: 2.39; 95% CI: 1.46-3.92; P < 0.001) and sudden cardiac death (adjusted HR: 3.26; 95% CI: 1.59-6.65; P = 0.001), together with left ventricular end-diastolic volume index, LGE, and ECV. Patients with non-TTN variants consistently had worse outcomes among patients with LGE presence, greater LGE extent, elevated ECV, and in both left ventricular ejection fraction strata (≤35% and >35%) (log-rank P < 0.05). Mediation analysis showed LGE (indirect HR: 1.26; 95% CI: 1.11-1.47; P = 0.008) and ECV (indirect HR: 1.29; 95% CI: 1.12-1.53; P = 0.006) partly mediated the association between non-TTN variants and adverse outcomes, whereas left ventricular end-diastolic volume index and left ventricular ejection fraction did not show significant mediating effects.
CONCLUSIONS: Genetic background was associated with distinct myocardial fibrosis phenotypes and provided prognostic information beyond conventional CMR-derived fibrosis and functional phenotypes in DCM. Myocardial fibrosis partly mediates the association between non-TTN variants and adverse outcomes.
引用
- Li, Xu, Guo, et al. Interaction Between Genotype, Phenotype, and Prognosis in Patients With Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2026. PMID: 42814072. doi:10.1016/j.jcmg.2026.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。